Accord Logo

Intended for UK patients and members of the public

SmPC- Temozolomide Accord 180mg Hard Capsules: Change history

  • Description of update: To update section 4.2, 4.8, 4.9, 5.1 and 5.3 of the SmPC, section 1, 2, 3, and 4 of the PIL and section C and D of the annex-II information in line with the information of reference product (Temodal 5mg, 20mg, 100mg, 140mg, 180mg, 250mg hard capsules; MAH: Merck Sharp & Dohme B.V. The Netherlands; EU procedure reference number:

    EMEA/H/C/000229 - IA/0099 updated on date 21/02/2023) for Temozolomide Accord 5/20/100/140/180/250mg capsules. In addition, editorial updates have been made to sections 3, 4.2,

    4.4, 4.6, 4.7 of SmPC and section 2 of leaflet with editorial changes in line with reference product Information.

    SmPC sections updated: 4.4, 4.9, 5.3, 10.

    • Changes: (Updated: 12 Jul 2023)

      Description of update: To update section 4.2, 4.8, 4.9, 5.1 and 5.3 of the SmPC, section 1, 2, 3, and 4 of the PIL and section C and D of the annex-II information in line with the information of reference product (Temodal 5mg, 20mg, 100mg, 140mg, 180mg, 250mg hard capsules; MAH: Merck Sharp & Dohme B.V. The Netherlands; EU procedure reference number:

      EMEA/H/C/000229 - IA/0099 updated on date 21/02/2023) for Temozolomide Accord 5/20/100/140/180/250mg capsules. In addition, editorial updates have been made to sections 3, 4.2,

      4.4, 4.6, 4.7 of SmPC and section 2 of leaflet with editorial changes in line with reference product Information.

      SmPC sections updated: 4.4, 4.9, 5.3, 10.

    • Changes: (Updated: 22 Sep 2022)

      initial upload

    View product information as a: